Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 9/12/25 → 9/12/27 |
Funding
- Iovance Biotherapeutics Incorporated: $2.00
24-LUN-137-IOV (IOV-LUN-202): A Phase 2 Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) in Patients with Metastatic Non-Small-Cell Lung Cancer
- Zinner, Ralph (PI)